secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDICINOVA INC (MNOV)
CIK:        0001226616
Form:       8-K
Filed at:   2026-08-19T11:30:06+00:00
Accession:  0001193125-26-356146
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MediciNova enters new employment agreements with CEO and CMO
------------------------------------------------------------

- CEO Dr. Yuichi Iwaki: base salary $690,246, bonus target 55% of base.
- CMO Dr. Kazuko Matsuda: base salary $540,143, bonus target 40% of base.
- Non-CIC severance: 12 months salary plus 12 months COBRA for both executives.
- CIC severance: CEO 24 months salary+bonus, CMO 18 months, both 100% equity vesting.
- Agreements effective Aug 17, 2026, replace prior arrangements; include 1-yr non-solicitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1226616/000119312526356146/0001193125-26-356146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1226616/000119312526356146/d407050d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-356146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer